Wyoming Tech Reporter
SEE OTHER BRANDS

Your best source on science and technology news from Wyoming

Wyoming Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wyoming Tech Reporter.

Press releases published on June 26, 2025

viggotech Achieves 94% Customer Retention and Profitability in Four Months with Human-AI Sales Platform

viggotech Achieves 94% Customer Retention and Profitability in Four Months with Human-AI Sales Platform

Photo Courtesy of Valeriia Miller ZUG, Switzerland, June 26, 2025 (GLOBE NEWSWIRE) -- viggotech, a Swiss-based AI company with operations in Dubai and North America, developing enterprise-grade automation, has reached profitability within four months of …

Intermap Technologies Announces Voting Results of the Annual General Meeting of Shareholders

Intermap Technologies Announces Voting Results of the Annual General Meeting of Shareholders

CALGARY, Alberta, June 26, 2025 (GLOBE NEWSWIRE) -- (TSX: IMP; OTCQB: ITMSF) – Intermap Technologies Corporation (“Intermap” or the “Company”) held its annual general meeting of shareholders (the “Meeting”) on June 26, 2025, at the offices of Norton Rose …

Jolie Kahn, CEO von AgriFORCE, nimmt am exklusiven Bitcoin Policy Summit 2025 in Washington, D.C., teil – Fokus liegt auf Stablecoins und digitaler Infrastruktur der Zukunft

Jolie Kahn, CEO von AgriFORCE, nimmt am exklusiven Bitcoin Policy Summit 2025 in Washington, D.C., teil – Fokus liegt auf Stablecoins und digitaler Infrastruktur der Zukunft

WASHINGTON, June 26, 2025 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. („AgriFORCE” oder das „Unternehmen”) (NASDAQ: AGRI; AGRIW), ein innovationsgetriebenes Agtech-Unternehmen mit Schwerpunkt auf geistigem Eigentum und nachhaltigen Lösungen für die …

Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN DIEGO, June 26, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced the closing of its …

Global Healthcare Technology Leader Selects Kneat

Global Healthcare Technology Leader Selects Kneat

LIMERICK, Ireland, June 26, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a leading healthcare technology and diagnostics company (“ …

Kane Biotech Announces Conversion of Demand Loan from Insider into an Unsecured Convertible Debenture and Annual General Meeting Voting Results

Kane Biotech Announces Conversion of Demand Loan from Insider into an Unsecured Convertible Debenture and Annual General Meeting Voting Results

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, June 26, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) announces that today it has completed its previously …

LET Mining launches smart cloud mining to easily earn passive income

LET Mining launches smart cloud mining to easily earn passive income

London, UK, June 26, 2025 (GLOBE NEWSWIRE) -- With the rapid development of digital assets, more and more people are looking for ways to participate in the cryptocurrency market without frequent operations, lower risks and more stable returns. To meet this …

Teva Releases Q2 2025 Aide Memoire

Teva Releases Q2 2025 Aide Memoire

TEL AVIV, Israel, June 26, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q2 2025 Aide Memoire is available on the “Investors” page on its website. Q2 2025 Aide Memoire Teva has prepared this …

ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP

ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP

First-in-human trial of AX-0810 will evaluate safety, tolerability, pharmacokinetics, and target engagement in healthy volunteers with initial data expected in Q4 2025 Marks the first submitted Clinical Trial Application (CTA) advancing ProQR’s Axiomer™ …

Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025

Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, held today a shareholders …

ATI Announces Leadership Transition

ATI Announces Leadership Transition

SUMMERVILLE, S.C., June 26, 2025 (GLOBE NEWSWIRE) -- Advanced Technology International (ATI) today announced that John Jansen has stepped down as Chief Executive Officer, effective immediately. The Board of Directors thanks Mr. Jansen for his contributions …

Earlyworks Co., Ltd. Granted Extension by Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements

Earlyworks Co., Ltd. Granted Extension by Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements

TOKYO, June 26, 2025 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (Nasdaq: ELWS) (the “Company” or “Earlyworks”), a Japanese company operating its proprietary private blockchain technology, Grid Ledger System (“GLS”), today announced that it has received a …

Regeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025

Regeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025

TARRYTOWN, N.Y., June 26, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2025 financial and operating results on Friday, August 1, 2025, before the U.S. financial markets open. …

Roadzen Reports Full Fiscal Year 2025 Financial Results; Fiscal Q4 Delivers 13.3% Revenue Growth, 99% Net Loss Reduction, and Continued Progress Towards Breakeven

Roadzen Reports Full Fiscal Year 2025 Financial Results; Fiscal Q4 Delivers 13.3% Revenue Growth, 99% Net Loss Reduction, and Continued Progress Towards Breakeven

Roadzen enters Fiscal Year 2026 with Momentum and Improved Operating Leverage Driven by Strong Performance in the U.S. and India and a $300+Million Pipeline Key Highlights – Fiscal Year 2025 1. Revenue Growth Returns in Q4 Roadzen reported full-year …

Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem’s Hormone-Free, On-Demand Prescription Contraceptive Gel

Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem’s Hormone-Free, On-Demand Prescription Contraceptive Gel

Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of 2026 Tech transfer underway with validation batch …

Achieve Life Sciences Announces Proposed Underwritten Public Offering

Achieve Life Sciences Announces Proposed Underwritten Public Offering

SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …

Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades

Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades

Omnicom cross-agency collaboration to drive technology-led, innovative launch strategy Partnership brings together promising science, top-tier talent, and advanced technologies to enable a faster, smarter, and more effective path to address a critical …

Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation

Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation

Smoking, the leading cause of preventable death and disease, continues to affect nearly 29 million adults in the U.S. alone If approved, cytisinicline will be the first new FDA-approved pharmacotherapy option for nicotine dependence in two decades More …

Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference

Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference

WAYNE, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it will provide a …

CorMedix Inc. Announces Proposed Public Offering of Common Stock

CorMedix Inc. Announces Proposed Public Offering of Common Stock

BERKELEY HEIGHTS, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it intends …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service